Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway

DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection

(2011) Zhiquan Wang et al.   ANNALS OF NEUROLOGY

Levodopa Activates Apoptosis Signaling Kinase 1 (ASK1) and Promotes Apoptosis in a Neuronal Model: Implications for the Treatment of Parkinson's Disease

(2011) Elizabeth A. Sabens Liedhegner et al.   CHEMICAL RESEARCH IN TOXICOLOGY

JNK3 Mediates Paraquat- and Rotenone-Induced Dopaminergic Neuron Death

(2010) Won-Seok Choi et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

A scanning peptide array approach uncovers association sites within the JNK/βarrestin signalling complex

(2009) Xiang Li et al.   FEBS LETTERS

Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease

(2009) Jing Pan et al.   NEUROCHEMISTRY INTERNATIONAL

The β-Arrestin-2 Scaffold Protein Promotes c-Jun N-terminal Kinase-3 Activation by Binding to Its Nonconserved N Terminus

(2008) Chun Guo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

How Does Arrestin Assemble MAPKs into a Signaling Complex?

(2008) Xiufeng Song et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration

(2008) Vincent Ries et al.   JOURNAL OF NEUROCHEMISTRY

MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE

(2008) L. H. Wang et al.   NEUROLOGY